|
Apr 17
|
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
|
|
Feb 20
|
Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025
|
|
Feb 15
|
Agios Pharmaceuticals price target lowered to $74 from $75 at Scotiabank
|
|
Feb 14
|
Agios' Q4 Loss Wider Than Expected, Pyrukynd Drives Revenues
|
|
Feb 14
|
Agios Pharmaceuticals Full Year 2024 Earnings: Beats Expectations
|
|
Feb 14
|
Agios Pharmaceuticals Inc (AGIO) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and ...
|
|
Feb 13
|
Agios Pharmaceuticals Reveals Encouraging Data From Rare Blood Disorder Study In Younger Patients Aged Below 18 Years
|
|
Feb 13
|
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 13
|
Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
|
|
Feb 13
|
Agios’ Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint
|
|
Feb 12
|
Agios Pharmaceuticals price target lowered to $54 from $55 at BofA
|
|
Feb 12
|
Agios Pharmaceuticals, Inc. (AGIO): A Cheap Biotech Stock to Invest In Now
|
|
Feb 6
|
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025
|
|
Jan 3
|
How to Navigate the Stock and Bond Markets in 2025
|
|
Jan 3
|
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
|
|
Dec 10
|
Here's Why Agios Stock Plummeted More Than 20% on Monday
|
|
Dec 10
|
Agios Pharmaceuticals price target raised to $75 from $53 at Scotiabank
|
|
Dec 6
|
Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?
|
|
Dec 5
|
Are Options Traders Betting on a Big Move in Agios (AGIO) Stock?
|
|
Dec 5
|
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios
|